Market Highlights:
Antihistamines are commonly used for the treatment of allergies across the globe. Food and pet allergies are prevalent in various parts of the world. Therefore, the global antihistamine drugs market is expected to grow at a significant rate due to an increase in prevalence of allergic conditions and other diseases, and demand for new drugs for the treatment of these diseases.
The global Antihistamine Drugs Market is expected to grow at a CAGR of 9.8% during the forecast period and is estimated to reach USD 280 million by 2023.
Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Antihistamine drugs market research report–Global forecast till 2023.”
Major players in antihistamine drugs market
Some of the key players in the global market are Johnson & Johnson Consumer Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Pfizer (U.S.), CVS pharmacy (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), and Prestige Brands Holdings, Inc. (U.S.)
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4266
Regional Analysis
The global antihistamine drugs market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas dominate the global antihistamine drugs market. It comprises of two regions namely North America and South America. North America in the largest market owing to development of new antihistamine drugs by major market players for the treatment of allergies.
In Europe, rising awareness about sedating and non-sedating antihistamine drugs and their side effects as well as precautionary awareness drives this market. Furthermore, increasing prevalence of allergy rhinitis is found in European nations which further propels the market growth.
Asia Pacific is the fastest growing and potential market for antihistamine drugs, whose growth is attributed to the rising awareness about allergic conditions and availability of medications for its treatment.
The Middle East & Africa is expected witness steady growth owing to the rising demand for drugs and healthcare resources in this region.
Segmentation:
The global antihistamine drugs market is segmented on the basis of types which includes sedating and non-sedating antihistamines. Sedating antihistamines are further sub-segmented into brompheniramine, chlorpheniramine, diphenhydramine, doxylamine, carbinoxamine and others. Non-sedating antihistamines are further sub-segmented into fexofenadine, loratadine, loratadine odt, and others.
On the basis of route of administration, the market is segmented into oral route, parenteral route and rectal route. Parenteral route segmented is further sub-segmented into intramuscular, subcutaneous and intravenous route.
On the basis of indication, the market is segmented into allergy, urticaria, dermatitis, and others. And on the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies and others.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/antihistamine-drugs-market-4266
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
The overall Alzheimer's drugs market was regarded at USD 4.0 billion out of 2015 owing to the extending ordinariness and rate speeds of this contamination and creating geriatric people base.
In 2015, it was surveyed that 47 million people were living with Alzheimer's Disease (AD) across the globe.
It generally occurs in the more settled people who are 65 years or more.
Furthermore, creating care level concerning its results, as midway dementia, is projected to help the interest.The improvement of new and imaginative advancements is relied upon to add to the development of the general market.
For example, the advancement of new cloud-based psychological appraisal frameworks is relied upon to move the development.
The presence and improvement of pipeline drugs, like LMTX by TauRx Pharmaceuticals Ltd., are required to emphatically affect the development of this industry.
